Literature DB >> 7714411

Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application.

P P Ellis1, D S Pfoff, D C Bloedow, M Riegel.   

Abstract

Flurbiprofen Na and diclofenac Na, two ocular antiinflammatory agents, were investigated to determine the aqueous humor concentrations in the human eye following topical application. One hundred sixty-five patients undergoing cataract surgery received a single drop of either diclofenac Na or flurbiprofen Na at selected times prior to the surgical procedure. Aqueous humor samples were aspirated at the beginning of surgery and a sensitive high-performance liquid chromatographic assay was used to determine the concentration of the antiinflammatory agent in the ocular fluid. Samples were obtained between 10 min and 24 hrs after a single instillation of the drug onto the cornea. The highest average concentration of diclofenac was 82 ng/ml at 2.4 hrs after instillation; concentrations remained above 20 ng/ml for over 4 hrs. Thereafter, between 3 and 16 ng/ml diclofenac could be assayed through 24 hrs. The highest average concentration of flurbiprofen, 60 ng/ml, was found at 2.0 hrs. The last detectable flurbiprofen concentration was measured at 7.25 hrs after instillation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7714411     DOI: 10.1089/jop.1994.10.677

Source DB:  PubMed          Journal:  J Ocul Pharmacol        ISSN: 8756-3320


  11 in total

1.  Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation.

Authors:  D Weinberger; Y Ron; H Lichter; I Rosenblat; R Axer-Siegel; Y Yassur
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Authors:  N M Davies; K E Anderson
Journal:  Clin Pharmacokinet       Date:  1997-09       Impact factor: 6.447

3.  Comparative effect of topical diclofenac and topical dexamethasone on anterior chamber flare and postoperative pain following rhegmatogenous retinal detachment surgery.

Authors:  Salim Ben Yahia; Rim Kahloun; Nesrine Abroug; Imene Kaibi; Ghassen Laadhari; Bechir Jelliti; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2016-01-12       Impact factor: 2.031

4.  Flurbiprofen, S(+), eyedrops: formulation, enantiomeric assay, shelf-life and pharmacology.

Authors:  A A van Sorge; P H Wijnen; J L van Delft; V M Coré-Bodelier; N J van Haeringen
Journal:  Pharm World Sci       Date:  1999-04

5.  Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit.

Authors:  J L Bellot; M Palmero; C García-Cabanes; R Espí; C Hariton; A Orts
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

6.  Diclofenac sodium and cyclosporin A inhibit human lens epithelial cell proliferation in culture.

Authors:  P Cortina; M J Gómez-Lechón; A Navea; J L Menezo; M C Terencio; M Diaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-03       Impact factor: 3.117

7.  Lack of effect of nitroglycerin on the diameter response of larger retinal arterioles in normal persons during hypoxia.

Authors:  Musa Yasin Kaya; Line Petersen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-30       Impact factor: 3.117

8.  Different cellular effects of four anti-inflammatory eye drops on human corneal epithelial cells: independent in active components.

Authors:  Mingli Qu; Yao Wang; Lingling Yang; Qingjun Zhou
Journal:  Mol Vis       Date:  2011-12-06       Impact factor: 2.367

9.  Nonsteroidal anti-inflammatory drugs for retinal disease.

Authors:  Scott D Schoenberger; Stephen J Kim
Journal:  Int J Inflam       Date:  2013-01-14

Review 10.  Topical nonsteroidal anti-inflammatory drugs for macular edema.

Authors:  Andrea Russo; Ciro Costagliola; Luisa Delcassi; Francesco Parmeggiani; Mario R Romano; Roberto Dell'Omo; Francesco Semeraro
Journal:  Mediators Inflamm       Date:  2013-10-21       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.